Picture of Scancell Holdings logo

SCLP Scancell Holdings Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual cashflow statement for Scancell Holdings, fiscal year end - April 30th, GBP millions except per share, conversion factor applied.

2021
April 30th
2022
April 30th
2023
April 30th
2024
April 30th
2025
April 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.8-3.77-14.3-9.12-15.3
Depreciation
Non-Cash Items8.3-8.843.11-8.531.69
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.4491.682.151.026.34
Change in Accounts Receivable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-7.8-10.2-8.14-15.7-6.4
Capital Expenditures-0.744-1.27-0.203-0.177-1.54
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0030.0040.2840.3550.336
Other Investing Cash Flow
Cash from Investing Activities-0.741-1.260.0810.178-1.2
Financing Cash Flow Items-1.41-0.537-0.537-1.24-0.741
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities46.1-0.928-0.74610.49.69
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash37.5-12.4-8.8-5.12.08